2,3-dinor, 6-keto-pgf1alpha is a lipid of Fatty Acyls (FA) class.
We collected disease MeSH terms mapped to the references associated with 2,3-dinor, 6-keto-PGF1alpha
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Balazy M et al. | Facile method for preparation of 2,3-dinor-6-keto PGF1 alpha, the major urinary metabolite of prostacyclin. | 1988 | Prostaglandins | pmid:3070630 |
Falardeau P et al. | Urinary levels of 2,3-dinor-6-oxo-PGF1 alpha: a reliable index of the production of PGI2 in the spontaneously hypertensive rat. | 1985 | Prostaglandins | pmid:3890022 |
Sun FF et al. | Preparation of two dinor-PGI2 metabolites from 6-keto-PGF1 alpha by Mycobacterium rhodochrous. | 1980 | Prostaglandins | pmid:6258195 |
Vesterqvist O and Gréen K | Development of a GC-MS method for quantitation of 2,3-dinor-6-keto-PGF1 alpha and determination of the urinary excretion rates in healthy humans under normal conditions and following drugs. | 1984 | Prostaglandins | pmid:6548317 |
Stichtenoth DO et al. | Increased total body synthesis of prostacyclin in rats with adjuvant arthritis. | 1995 Nov-Dec | Prostaglandins | pmid:8838242 |
Schaefer WR et al. | Urinary excretion of 2,3-dinor-6-keto-PGF1 alpha and 11-dehydro-TXB2 by the gravid spontaneously hypertensive rat. | 1996 | Prostaglandins | pmid:8875634 |
Hotter G et al. | Altered levels of tissue and urinary prostacyclin in rats subjected to pancreas transplantation. | 1991 | Prostaglandins | pmid:2052738 |
Ylikorkala O et al. | Urinary excretion of prostacyclin and thromboxane metabolites in climacteric women: effect of estrogen-progestin replacement therapy. | 1990 | Prostaglandins | pmid:2106714 |
Henriksson P et al. | Thromboxane synthase inhibition: "endoperoxide shunt phenomenon" does not occur in healthy humans in vivo. | 1990 | Prostaglandins | pmid:2106716 |
Grèen K et al. | Pronounced reduction of in vivo prostacyclin synthesis in humans by acetaminophen (paracetamol). | 1989 | Prostaglandins | pmid:2664901 |